Can AI Clear the Echocardiogram Backlog? NICE's Verdict on Heart Failure Tech

NICE weighs in on 4 AI technologies designed to speed up echocardiography for heart failure diagnosis. Despite incredible claims of time savings, the agency stops short of recommending NHS funding. Maya and Sam unpack the evidence gaps, the economic models, and what AI builders need to prove before winning health-system adoption.

Key points

• NICE published an early-use assessment in May 2026 on 4 AI echocardiography tools: EchoConfidence, EchoGo Heart Failure, Ligence Heart, and Us2.ai.
• None of the technologies are recommended for NHS funding yet; access should remain through company, research, or non-core funding.
• While AI reduced analysis time in some studies—from 587 seconds to 3.2 seconds—it is uncertain if this translates to reduced waiting lists in the real world.
• The clinical evidence lacked generalisability, with many studies being retrospective, outside the UK, and excluding poor-quality scan images.
• Economic modeling showed potential cost savings or acceptable cost-effectiveness, but results are highly uncertain without real-world procedure time data.

Source: Artificial intelligence (AI)-assisted echocardiography analysis and reporting to support the diagnosis and monitoring of heart failure: early-use assessment - National Institute for Health and Care Excellence

This spot is available. Reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsor the show

This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/can-ai-clear-the-echocardiogram-backlog-nice-s-verdict-on-heart-failur-95f0af